Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-06-17 16:45:12 ET · period of report 2026-06-15 · accession 0001756253-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-17 16:45 | 2026-06-15 | JAZZ | Smith Mark Douglas | Dir | S - Sale | $230.55 | -1,157 | 9,680 | -11% | -$266.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-15 | S | D | 1,157 | $230.55 | 9,680 | D | — | — | (F1) This transaction was made pursuant to a plan adopted by the reporting person on March 9, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |